The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients

European Journal of Cancer

Volumn 44, Issue 7, 2008, Pages 1000-1006

  Wang, Jing Houng ^a   Changchien, Chi Sin ^a   Hu, Tsung Hui ^a   Lee, Chuan Mo ^a   Kee, Kwong Ming ^a   Lin, Chih Yun ^a   Chen, Chao Long ^b   Chen, Tai Yi ^b   Huang, Yu Jie ^b   Lu, Sheng Nan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Barcelona Clinic Liver Cancer (BCLC) staging; Hepatocellular carcinoma; Survival analysis; Treatment options

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; TAMOXIFEN;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL TIME;

APPOINTMENTS AND SCHEDULES; CARCINOMA, HEPATOCELLULAR; EPIDEMIOLOGIC METHODS; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SPAIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 42649135205     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.02.018     Document Type: Article

References (30)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer 94 (2000) 153-156
2. Department of Health: Health statistics, 2004. Taipei, Department of Health, Executive Yuan, Republic of China, 2005.
3. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusion of the Barcelona-2000 EASL Conference. J Hepatol 35 (2001) 421-430
4. Wildi S., Pestalozzi B.C., McCormack L., and Clavien P.A. Critical evaluation of the different staging systems for hepatocellular carcinoma. Br J Sur 91 (2004) 400-408
5. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
6. Llovet J.M., Bru C., and Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging system. Semin Liver Dis 19 (1999) 329-338
7. Marrero J.A., Fontana R.J., Barrat A., et al. Prognosis of hepatocellualr carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 41 (2005) 707-716
8. Grieco A., Pompili M., Caminiti G., et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian center. Gut 54 (2005) 411-418
9. Cillo U., Vitale A., Grigoletto F., et al. Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol 44 (2006) 723-731
10. Pascual S., Zapater P., Such J., et al. Comparison of staging systems to predict survival in hepatocellular carcinoma. Liver Int 26 (2006) 673-679
11. Cheng Y., Kan Z., Chen C., et al. Efficacy and safety of preoperative lobar or segmental ablation via transarterial administration of ethiodol and ethanol mixture for treatment of hepatocellular carcinoma: clinical study. World J Surg 24 (2000) 844-850
12. Okuda K., Ohtsuki T., Obata H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56 (1985) 918-928
13. The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000:31:840-845.
14. Leung T.W., Tang A.M., Zee B., et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer 94 (2002) 1760-1769
15. Chevret S., Trinchet J.C., Mathieu D., Rached A.A., Beaugrand M., Chastang C., et al. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. J Hepatol 31 (1999) 133-141
16. Kudo M., Chung H., and Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 38 (2003) 207-215
17. Kudo M., Chung H., Haji S., et al. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology 40 (2004) 1396-1405
18. Tateishi R., Yoshida H., Shiina S., et al. Proposal of new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut 54 (2005) 419-425
19. Ikai I., Takayasu K., Omata M., et al. A modified Japan integrated stage score for prognostic assessment in patients with hepatocellular carcinoma. J Gastroenterol 41 (2006) 250-256
20. Toyoda H., Kumada T., Kiriyama S., et al. Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan. Am J Gasteroenterol 100 (2005) 1764-1771
21. Kudo M. What is the best staging system for hepatocellular carcinoma?. J Gastroenterol 41 (2006) 290-291
22. Llovet J.M., and Bruix J. Systemic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37 (2003) 429-442
23. Takayasu K., Arii S., Ikai I., et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131 (2006) 461-469
24. Hawkins M.A., and Dawson L. Radiation therapy for hepatocellular carcinoma. From palliation to cure. Cancer 106 (2006) 1653-1663
25. Llovet J.M., Schwartz M., and Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25 (2005) 181-200
26. Llovet J.M., and Sala M. Non-surgical therapies of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 17 (2005) 505-513
27. Huang G.T., Lee P.H., Tsang Y.M., et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg. 242 (2005) 36-42
28. Lin S.M., Lin C.J., Lin C.C., Hsu C.W., and Chen Y.C. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4cm. Gastroenterology 127 (2004) 1714-1723
29. Shina S., Teratani T., Obi S., et al. Randomized controlled trial of radiofrequency with ethanol injection for small hepatocelllar carcinoma. Gastroenterology 129 (2005) 122-130
30. Lencioni R.A., Allgaier H.P., Cioni D., et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 228 (2003) 235-240